New Drug Cuts Tourette Tics in Half Without Side Effects

A breakthrough medication could become the first FDA-approved treatment designed specifically for children with Tourette syndrome, reducing tics by 50% without the harsh side effects of current drugs.

After a successful Phase III trial across 77 sites, the drug ecopipam is heading for FDA review.